INR

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instance_of gptkb:tools
gptkbp:calculated_from prothrombin time (PT)
gptkbp:can risk of bleeding
gptkbp:components thromboprophylaxis
gptkbp:developed_by gptkb:World_Health_Organization
gptkbp:has_sections patients on warfarin
https://www.w3.org/2000/01/rdf-schema#label INR
gptkbp:is_a_critical_parameter_for patient outcomes
gptkbp:is_a_critical_value_for emergency medicine
gptkbp:is_a_guide_for clinical decision making
treatment protocols
dosage adjustments
gptkbp:is_a_key_measure_in preventive medicine
gptkbp:is_a_standard_measure_for warfarin therapy
gptkbp:is_affected_by vitamin K intake
gptkbp:is_analyzed_in bleeding disorders
antithrombotic therapy
anticoagulation levels
therapeutic ranges
gptkbp:is_associated_with various medications
gptkbp:is_calculated_to_ensure therapeutic effectiveness
gptkbp:is_essential_for patient safety
surgical procedures
preventing blood clots
patients with atrial fibrillation
long-term anticoagulation management
gptkbp:is_evaluated_by the INR formula
gptkbp:is_expressed_in a numerical value
gptkbp:is_influenced_by liver function
gptkbp:is_monitored_by thromboembolic events
point-of-care testing devices
patients with mechanical heart valves
gptkbp:is_part_of coagulation profile
gptkbp:is_related_to thrombosis
gptkbp:is_relevant_to cardiovascular health
gptkbp:is_standardized_by anticoagulation therapy
anticoagulant therapy monitoring
patient management in anticoagulation therapy
gptkbp:is_used_in clinical trials
clinical settings
gptkbp:key_feature coagulation status
gptkbp:measures laboratories
vitamin K antagonism
blood coagulation
blood thinning effectiveness
clotting time
gptkbp:normal_range 0.8 to 1.1
gptkbp:reported_by a ratio
gptkbp:used_for monitoring anticoagulant therapy
gptkbp:was_a_factor_in clinical assessments
patient management
stroke prevention
gptkbp:bfsParent gptkb:Stripe
gptkb:India
gptkbp:bfsLayer 4